Breast cancer is a highly heterogenous neoplasm which is typically classified immunohistochemically for the presence or absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.